A Lesson to Learn: Jasper Therapeutics Inc. (JSPR) – News Heater
Home  »  Business   »  A Lesson to Learn: Jasper Therapeutics Inc. (JSPR)...

A Lesson to Learn: Jasper Therapeutics Inc. (JSPR)

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Jasper Therapeutics Inc. (NASDAQ:JSPR) went up by 111.23% from its latest closing price compared to the recent 1-year high of $15.80. The company’s stock price has collected -9.87% of loss in the last five trading sessions. Press Release reported on 09/24/21 that Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded Biotechnology Company Dedicated to Enabling Cures Through Hematopoietic Stem Cell Therapy

Is It Worth Investing in Jasper Therapeutics Inc. (NASDAQ :JSPR) Right Now?

Opinions of the stock are interesting as 0 analysts out of 0 who provided ratings for Jasper Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Today, the average trading volume of JSPR was 474.58K shares.

JSPR’s Market Performance

JSPR stocks went down by -9.87% for the week, with a monthly drop of -27.79% and a quarterly performance of -27.39%, while its annual performance rate touched -26.20%. The volatility ratio for the week stands at 17.33% while the volatility levels for the past 30 days are set at 19.07% for Jasper Therapeutics Inc.. The simple moving average for the period of the last 20 days is 51.95% for JSPR stocks with a simple moving average of 51.87% for the last 200 days.

Analysts’ Opinion of JSPR

Many brokerage firms have already submitted their reports for JSPR stocks, with Oppenheimer repeating the rating for JSPR by listing it as a “Outperform.” The predicted price for JSPR in the upcoming period, according to Oppenheimer is $21 based on the research report published on October 13th of the current year 2021.

JSPR Trading at 52.59% from the 50-Day Moving Average

After a stumble in the market that brought JSPR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.61% of loss for the given period.

Volatility was left at 19.07%, however, over the last 30 days, the volatility rate increased by 17.33%, as shares surge +43.74% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +44.83% upper at present.

During the last 5 trading sessions, JSPR rose by +73.43%, which changed the moving average for the period of 200-days by +43.60% in comparison to the 20-day moving average, which settled at $10.24. In addition, Jasper Therapeutics Inc. saw -27.97% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for JSPR

Equity return is now at value -4.80, with -4.30 for asset returns.

>> 7 Top Picks for the Post-Pandemic Economy <<

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.42.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam